Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2725781994;81995;81996 chr2:178564363;178564362;178564361chr2:179429090;179429089;179429088
N2AB2561677071;77072;77073 chr2:178564363;178564362;178564361chr2:179429090;179429089;179429088
N2A2468974290;74291;74292 chr2:178564363;178564362;178564361chr2:179429090;179429089;179429088
N2B1819254799;54800;54801 chr2:178564363;178564362;178564361chr2:179429090;179429089;179429088
Novex-11831755174;55175;55176 chr2:178564363;178564362;178564361chr2:179429090;179429089;179429088
Novex-21838455375;55376;55377 chr2:178564363;178564362;178564361chr2:179429090;179429089;179429088
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: P
  • RefSeq wild type transcript codon: CCA
  • RefSeq wild type template codon: GGT
  • Domain: Fn3-86
  • Domain position: 88
  • Structural Position: 120
  • Q(SASA): 0.3141
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
P/L None None 1.0 D 0.829 0.451 0.763603987931 gnomAD-4.0.0 1.59149E-06 None None None None N None 0 0 None 0 0 None 0 0 2.85835E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
P/A 0.1565 likely_benign 0.1406 benign -1.344 Destabilizing 1.0 D 0.732 prob.delet. N 0.483988857 None None N
P/C 0.8474 likely_pathogenic 0.8246 pathogenic -0.915 Destabilizing 1.0 D 0.827 deleterious None None None None N
P/D 0.9686 likely_pathogenic 0.9613 pathogenic -0.976 Destabilizing 1.0 D 0.765 deleterious None None None None N
P/E 0.8923 likely_pathogenic 0.8664 pathogenic -1.038 Destabilizing 1.0 D 0.767 deleterious None None None None N
P/F 0.8497 likely_pathogenic 0.8005 pathogenic -1.228 Destabilizing 1.0 D 0.848 deleterious None None None None N
P/G 0.6828 likely_pathogenic 0.6348 pathogenic -1.582 Destabilizing 1.0 D 0.793 deleterious None None None None N
P/H 0.7653 likely_pathogenic 0.7067 pathogenic -1.011 Destabilizing 1.0 D 0.82 deleterious None None None None N
P/I 0.8015 likely_pathogenic 0.7758 pathogenic -0.821 Destabilizing 1.0 D 0.873 deleterious None None None None N
P/K 0.8895 likely_pathogenic 0.8625 pathogenic -1.014 Destabilizing 1.0 D 0.769 deleterious None None None None N
P/L 0.5985 likely_pathogenic 0.5415 ambiguous -0.821 Destabilizing 1.0 D 0.829 deleterious D 0.534275923 None None N
P/M 0.8145 likely_pathogenic 0.7798 pathogenic -0.592 Destabilizing 1.0 D 0.817 deleterious None None None None N
P/N 0.9307 likely_pathogenic 0.9119 pathogenic -0.731 Destabilizing 1.0 D 0.851 deleterious None None None None N
P/Q 0.7772 likely_pathogenic 0.731 pathogenic -1.001 Destabilizing 1.0 D 0.805 deleterious D 0.529302401 None None N
P/R 0.8276 likely_pathogenic 0.7805 pathogenic -0.407 Destabilizing 1.0 D 0.855 deleterious N 0.512666176 None None N
P/S 0.5531 ambiguous 0.4914 ambiguous -1.226 Destabilizing 1.0 D 0.769 deleterious N 0.505157758 None None N
P/T 0.5909 likely_pathogenic 0.5495 ambiguous -1.188 Destabilizing 1.0 D 0.767 deleterious D 0.547153166 None None N
P/V 0.6575 likely_pathogenic 0.6322 pathogenic -0.96 Destabilizing 1.0 D 0.791 deleterious None None None None N
P/W 0.9483 likely_pathogenic 0.9331 pathogenic -1.286 Destabilizing 1.0 D 0.805 deleterious None None None None N
P/Y 0.8445 likely_pathogenic 0.7993 pathogenic -1.03 Destabilizing 1.0 D 0.861 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.